Eloxx Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY1999 | -128.2% | -128.2% | — |
| FY2000 | -220.4% | -220.4% | — |
| FY2001 | 983.9% | 983.9% | — |
| FY2002 | -63.1% | -63.1% | — |
| FY2003 | -97.3% | -97.3% | — |
| FY2004 | -78.8% | -78.8% | — |
| FY2005 | -53.3% | -53.3% | — |
| FY2006 | -112.3% | -112.3% | — |
| FY2007 | -120.9% | -120.9% | — |
| FY2008 | -46.8% | -46.8% | — |
| FY2009 | -101.0% | -101.0% | — |
| FY2010 | -167.7% | -167.7% | — |
| FY2011 | -160.9% | -160.9% | -84.6% |
| FY2012 | -146.7% | -146.7% | -72.8% |
| FY2013 | -161.7% | -161.7% | -86.3% |
| FY2014 | -332.4% | -332.4% | -27.7% |
| FY2015 | -996.3% | -996.3% | -32.8% |
| FY2016 | -1,614.3% | -1,614.3% | -314.8% |
| FY2017 | -99.3% | -99.3% | -85.6% |
| FY2018 | -110.0% | -110.0% | -93.0% |
| FY2019 | -140.5% | -108.9% | -86.3% |
| FY2020 | -338.0% | -208.2% | -130.6% |
| FY2021 | -298.1% | -194.1% | -147.8% |
| FY2022 | 338.3% | 1,714.9% | -170.7% |
| FY2023 | 75.5% | 81.3% | -996.1% |
| FY2024 | 12.9% | 12.9% | -105.6% |
| FY2025 | 50.3% | 50.3% | -113.8% |